Friday 6 November 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.

Revenue: +4.13%
EPS: −21.7%
Free cash flow: −63.7%

Quarter to September 2026, against a year earlier

561.51 4.21 −0.74%

Follow UTHR

Alert me

Market cap: $24.3B
P/E: 19.7×
Fwd P/E: 22.5×
Dividend yield: —
F-score: 8/9
Altman Z: 19.55
Beneish M: −2.26
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	16.14	20.22	17.89	18.94
P/S ratio Full definition →		6.78	8.14	7.32	7.26
P/FCF ratio Full definition →		20.85	25.50	21.22	26.85
P/Operating CF Full definition →		62.35	55.68	73.60	73.78
P/B ratio Full definition →		3.04	4.37	3.61	3.62
Price to Tangible BV Full definition →		3.09	4.46	3.67	3.68
EV/Sales Full definition →		5.96	7.55	6.57	6.24
EV/EBITDA Full definition →		12.02	15.71	13.88	14.04
EV/Operating CF Full definition →		12.15	15.31	12.30	13.92
EV/FCF Full definition →		18.32	23.67	19.05	23.10
Quick Ratio Full definition →		5.83	4.12	4.89	4.66
Current Ratio Full definition →		6.60	4.79	5.73	4.66
Net Debt/EBITDA Full definition →		(7.70)	(6.18)	(7.50)	0.00
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.42	0.44	0.42	0.44
Operating CF/Net income Full definition →		0.95	1.69	0.94	0.00
Capex/Depreciation Full definition →		(7.58)	(4.46)	(4.46)	(6.84)
Interest Coverage Full definition →		115.06	108.60	114.07	106.14
Research and Development Expense of Revenue Full definition →		17.65%	17.68%	18.68%	33.54%
Selling, General and Administrative Expense of Revenue Full definition →		24.12%	23.56%	26.39%	17.59%
Intangible Assets out of Total Assets Full definition →		0.01	0.02	0.02	0.00
Share Based Compensation of Revenue Full definition →		4.94%	4.34%	5.54%	0.00%
Graham Net Nets Full definition →		0.14	0.08	0.12	0.12
Graham Number Full definition →		329.81	299.15	319.94	0.00
Earnings Yield Full definition →		6.19%	4.94%	5.59%	5.28%
Free Cash Flow Yield Full definition →		4.80%	3.92%	4.71%	3.72%
Revenue per Share Full definition →		17.84	17.97	18.39	19.50
Operating CF per Share Full definition →		7.81	10.65	7.36	0.00
Capex per Share Full definition →		(3.90)	(2.32)	(2.54)	0.00
Free Cash Flow per Share Full definition →		3.91	8.33	4.83	0.00
Cash per Share Full definition →		65.92	49.51	62.50	82.80
Shareholders Equity per Share Full definition →		160.19	135.66	150.24	146.98
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		160.19	135.66	150.24	146.98
Free Cash Flow Full definition →		173.30	362.50	205.60	125.80
Working Capital Full definition →		3,141.90	2,272.90	2,875.90	2,777.60
Capital Expenditures Full definition →		(172.90)	(100.80)	(108.00)	(180.70)
Net Current Asset Value Full definition →		2,918.70	2,058.90	2,663.90	2,777.60
EV/EBIT Full definition →		12.71	16.68	14.78	15.07
Capex to Sales Full definition →		0.22	0.13	0.14	0.00
Price to Operating Income Full definition →		14.46	17.97	16.47	17.51
Other line items
Average Receivables Full definition →		314.75	317.00	344.80	323.15
Average Payables Full definition →		416.25	432.65	464.90	494.10
Average Inventory Full definition →		170.50	171.85	181.50	189.20
Average Assets Full definition →		7,622.00	7,229.05	7,564.05	7,192.60
Average Common Equity Full definition →		6,770.10	6,354.15	6,786.95	6,433.10

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly